Okay, let's tackle this question about Bleomycin in the context of Hodgkin's lymphoma. The user provided the question but didn't fill in the options. Hmm, but the correct answer is given as something else. Wait, the user mentioned the correct answer is false regarding Bleomycin. So I need to figure out which statement is false.

First, I should recall the key points about Bleomycin. Bleomycin is an antineoplastic antibiotic used in Hodgkin's lymphoma, often part of the ABVD regimen. Its major side effects include pulmonary toxicity (like interstitial pneumonitis or pulmonary fibrosis) and, interestingly, it can cause hyperpigmentation. It's also known for causing alopecia, but that's a temporary side effect. Another point is that it's a vesicant, so extravasation can be a problem if given intravenously. Oh, and it's administered via IV, not orally.

Now, the question is asking which statement is false. Let's think of common false statements. If one of the options says that Bleomycin is associated with cardiotoxicity, that's incorrect because cardiotoxicity is more commonly linked to Doxorubicin. Another possible false statement could be that it's a DNA alkylating agent. No, Bleomycin works by binding to DNA and causing single-strand breaks, catalyzed by iron. So if an option says it's an alkylating agent, that's wrong. Also, if an option mentions that it's given orally, that's false because it's only given IV. Another false point might be that it's used in the treatment of solid tumors, but actually, it's more for lymphomas and germ cell tumors.

So, if the options include something about cardiotoxicity, oral administration, alkylating mechanism, or non-lymphoma use, those would be the false statements. The correct answer would be the one that incorrectly attributes a side effect or mechanism. Let's structure the explanation with these points in mind.

**Core Concept**
Bleomycin is an antineoplastic antibiotic used in Hodgkin's lymphoma. Its key adverse effects include pulmonary toxicity, hyperpigmentation, and alopecia. Mechanistically, it induces DNA strand breaks via iron-dependent free radical formation.

**Why the Correct Answer is Right**
The false statement is likely related to **cardiotoxicity**. Bleomycin does **not** cause cardiotoxicity; this is a hallmark of anthracyclines like doxorubicin. Its primary toxicity is pulmonary (interstitial fibrosis), requiring monitoring via pulmonary function tests.

**Why Each Wrong Option is Incorrect**
**Option A:** If stating "Bleomycin causes pulmonary toxicity" – this is **correct**, as pulmonary fibrosis is a major adverse effect.
**Option B:** If claiming "Bleomycin induces alopecia" – this is **correct**, as hair loss is a common side effect.
**Option C:** If asserting "Bleomycin is a vesicant" – this is **correct**, as extravasation can lead to tissue necrosis.
**Option D:** If suggesting "Bleomycin is administered orally" – this is **incorrect**, as it is given intravenously or via nebulization.

**Clinical Pearl / High-Yield Fact**
Remember the

✓ Correct Answer: D. It has high risk of causing bone marrow suppression